Luo Lih Fen Holding Co Ltd

Luo Lih Fen maintains a strong liquidity position with a current ratio of 1.88 and a price-to-book ratio of 1.15, indicating a relatively conservative capital structure. The company's liquidity_fpt score of 0.89 suggests it has sufficient short-term assets to cover its liabilities, supported by cash and equivalents of TWD 221.8 million. The low debt-to-equity ratio of 0.03 further reinforces its financial stability, with long-term debt amounting to only TWD 52.4 million against total equity of TWD 1.7 billion. Profitability metrics show a return on equity (ROE) of 6.74% and a return on assets (ROA) of 4.96%, which are below the industry median for personal care products. The company's gross margin of 65.5% (TWD 728.7 million gross profit on TWD 1.11 billion revenue) is in line with industry norms, but its operating margin of 10.8% (TWD 120.3 million operating income) is slightly below the median for the sector. Net income of TWD 114.7 million represents a net margin of 10.3%, which is consistent with the industry's average profitability. The company's revenue is concentrated in its core personal care and medical device product lines, with no disclosed geographic diversification in the financial snapshot. This suggests a high degree of revenue concentration in its primary markets, which could expose the company to regional economic or regulatory risks. The lack of geographic breakdown in the input data limits the ability to assess exposure to specific regions or markets. Looking ahead, the company's revenue is projected to grow by 4.2% in the current fiscal year and 3.8% in the next fiscal year, based on the outlook data. This growth is modest compared to the industry's average growth rate of 6.5% for the current year and 5.1% for the next year. The company's free cash flow of TWD 46.98 million is expected to support reinvestment and shareholder returns, but the capital expenditure of TWD -25.83 million indicates a reduction in investment in physical assets. Risk factors for Luo Lih Fen include low liquidity and dilution risk, with no immediate filing-based flags detected. The company's liquidity risk is low due to its strong cash position and low debt levels. However, the absence of dilution risk does not preclude future capital-raising activities, especially if the company seeks to expand its product lines or geographic reach. The risk assessment indicates a low probability of dilution in the near term, with no near-term pressure expected. Recent events, as reflected in the financial data, show a stable financial performance with consistent revenue and profit growth. The company's operating cash flow of TWD 497.7 million and free cash flow of TWD 46.98 million indicate strong cash generation capabilities. The absence of recent filings or transcripts in the input data limits the ability to assess any recent strategic or operational changes.